Antioxytocin activity of propranolol, INPEA and their optical isomers on the isolated rat uterus.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000008:administration & dosage / Q000494:pharmacology*; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D003864:Depression, Chemical; D004357:Drug Synergism; D005260:Female; D007734:Kymography; D008027:Light; D009119:Muscle Contraction; D009578:Nitrobenzenes / Q000008:administration & dosage / Q000494:pharmacology*; D010121:Oxytocin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D011343:Procaine / Q000008:administration & dosage / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D012399:Rotation; D013237:Stereoisomerism; D013997:Time Factors; D014599:Uterus / Q000187:drug effects* / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000779:Anesthetics, Local; D009578:Nitrobenzenes; D010627:Phenethylamines; D011343:Procaine; D010121:Oxytocin; D011433:Propranolol